login
Password reminder
Interventional News
Contact the editor Visit Interventional News Twitter feed Visit Interventional News Facebook page
 



a b c d e f g h i j k l m n
o p q r s t u v w x y z


1 - 10 of 51   Items
Two millimetre “ice ball” margin beyond renal tumours adequate for effective cryoablation

Two millimetre “ice ball” margin beyond renal tumours adequate for effective cryoablation

Thursday, 12 Jun 2014
The results from a small, animal study challenge previously unsubstantiated published reports claiming that a five to 10mm “ice ball” margin beyond the tumour is necessary for effective cryoablation. Two millimetre “ice ball” margin beyond renal tumours adequate for effective cryoablation
MicroThermX microwave ablation system at CIRSE

MicroThermX microwave ablation system at CIRSE

Tuesday, 20 Sep 2011
The MicroThermX microwave ablation system (BSD Medical) was featured at BSD’s exhibition booth at the international meeting of the Cardiovascular and Interventional Radiological Society of Europe (CIRSE), which was held in Munich, Germany, (10-14 September 2011). MicroThermX microwave ablation system at CIRSE
Positive phase II trial results from the neuroendocrine tumor cohort (mNET) of Delcath’s chemosaturation system

Positive phase II trial results from the neuroendocrine tumor cohort (mNET) of Delcath’s chemosaturation system

Monday, 19 Sep 2011
Overall hepatic response rate with chemosaturation treatment among patients was 70%. On the other hand, 30.4 months was the median overall survival in all patients. Positive phase II trial results from the neuroendocrine tumor cohort (mNET) of Delcath’s chemosaturation system

Hepatic chemosaturation—an emerging therapy in interventional oncology

Tuesday, 22 Feb 2011
Hepatic chemosaturation is a minimally invasive technique which delivers high doses of chemotherapy into the liver to more effectively battle tumours, while limiting toxicity to the rest of the body, making it safer than intrahepatic artery perfusion. Hepatic chemosaturation—an emerging therapy in interventional oncology

Radioembolisation prolongs life for inoperable HCC patients

Monday, 12 Jul 2010
More than three-fourths of hepatocellular carcinoma patients are not surgical candidates and radioembolisation with intra-arterial yttrium-90 extends patient survival. Radioembolisation prolongs life for inoperable HCC patients

Direct injection of gold nanoparticles into tumours could be a new treatment for pancreatic cancer

Monday, 12 Jul 2010
A radical new approach to the treatment of the disease, Reed A Omary claims. Direct injection of gold nanoparticles into tumours could be a new treatment for pancreatic cancer
North American Scientific signs definitive agreement

North American Scientific signs definitive agreement

Tuesday, 25 Sep 2007
Nomos Radiation Oncology business sold: September 2007 North American Scientific signs definitive agreement
CMS selected to provide treatment for New Proton Therapy Center

CMS selected to provide treatment for New Proton Therapy Center

Tuesday, 25 Sep 2007
CMS has been selected by ProCure Treatment Centers: September 2007 CMS selected to provide treatment for New Proton Therapy Center
Visualase announces successful treatment of brain metastases

Visualase announces successful treatment of brain metastases

Tuesday, 25 Sep 2007
completed treatment of the first six patients: September 2007 Visualase announces successful treatment of brain metastases
CMS collaborates with Still River Systems

CMS collaborates with Still River Systems

Tuesday, 25 Sep 2007
CMS to provide treatment planning support: September 2007 CMS collaborates with Still River Systems
Found: 51   Displaying: 1-10
Results: 1 2 3 4 5 Next Go to:

Related Section


Oncology Useful Links

Most popular


Biolas introduces VariClose in Europe
Thursday, 16 Jul 2015
After the European launch in April 2015, Biolas has introduced the VariClose Vein Sealing Systems in the European market for the treatment of varicose veins. Biolas introduces VariClose in Europe

Lombard Medical acquires EVAR stent graft developer Altura Medical
Friday, 31 Jul 2015
Altura Medical has developed an ultra-low profile endovascular stent graft technology that, according to Lombard, offers a simple and predictable solution for the treatment of standard abdominal ... Lombard Medical acquires EVAR stent graft developer Altura Medical

Sorry, I don’t speak IR
Wednesday, 12 Aug 2015
Two recently published papers in the Journal of Vascular and Interventional Radiology (JVIR) reveal that patient materials in interventional radiology available online are way above the understanding ... Sorry, I don’t speak IR

Features


Patient selection is key for SIRT with first-line chemotherapy
Tuesday, 18 Aug 2015
Ricky Sharma, professor and honorary consultant of Clinical Oncology at the University of Oxford and Oxford University Hospitals Trust tells Interventional News: “We need to know more about patient ... Patient selection is key for SIRT with first-line chemotherapy

Choosing horses for courses: Using liquid agents to embolize endoleaks
Monday, 27 Jul 2015
Robert Morgan, vascular interventional radiologist, St Georges Hospital, London, UK, tells Interventional News why he uses liquid embolic agents, such as ethylene vinyl oxide copolymer (EVOH-based) ... Choosing horses for courses: Using liquid agents to embolize endoleaks

Profiles


Lindsay Machan
Thursday, 28 May 2015
“Focusing on maximising rewards has sidelined more ideas than it has helped individual inventors. S... Lindsay Machan

Gao-Jun Teng
Thursday, 11 Dec 2014
In the future, will interventional radiology be a subspecialty of radiology, or surgery? asks Gao-J... Gao-Jun Teng

Cardiac Rhythm News Vascular News Cardiovascular News Interventional News Spinal News NeuroNews
BIBA Medical BIBA MedTech Insights CX Symposium ilegx
Password Reminder

BIBA Medical, 526 Fulham Road, Fulham, London, SW6 5NR.
TEL: +44 (0)20 7736 8788 FAX: +44 (0)20 7736 8283 EMAIL: 
info@bibamedical.com
© BIBA Medical Ltd is a company registered in England and Wales with company number 2944429.
VAT registration number 730 6811 50.
Site Map | Terms and Conditions